Ravgen
Columbia
About Ravgen
Ravgen specializing in non-invasive prenatal genetic testing and paternity testing, Ravgen is focused on developing non-invasive prenatal diagnostic tests based on fetal DNA present in maternal blood. Diagnose single gene disorders, such as cystic fibrosis, sickle cell anemia and Downs syndrome, establish paternity and more early on in pregnancy.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $3.6M
- Funding stage: Seed
- Last round: Debt Financing (Jun 2021)
- Website: ravgen.com
- Phone: 410-715-2111
Industries & Categories
Biotechnology, Genetics, Health Care
Social Profiles
Canonical: https://fsome.com/organization/ravgen-99386 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.